RNA binding by the NS3 protease of the hepatitis C virus

Virus Research

Volumn 169, Issue 1, 2012, Pages 80-90

  Vaughan, Robert ^a   Li, Yi ^b   Fan, Baochang ^a   Ranjith Kumar, C T ^a   Kao, C Cheng ^a  

^a INDIANA UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

ATPase activation; Hepatitis C virus; NS3 protease; Nucleic acid inhibitors; Positive strand RNA virus; RNA binding

Indexed keywords

ADENOSINE TRIPHOSPHATASE; HELICASE; NONSTRUCTURAL PROTEIN 3; PROTEINASE; SINGLE STRANDED RNA;

ARTICLE; CARBOXY TERMINAL SEQUENCE; ENZYME ACTIVATION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RNA BINDING; RNA REPLICATION;

BINDING SITES; HEPACIVIRUS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEOLYSIS; RNA; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 84867213168     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2012.07.007     Document Type: Article

References (67)

1. Beran R.K., Pyle A.M. Hepatitis C viral NS3-4A protease activity is enhanced by the NS3 helicase. Journal of Biological Chemistry 2008, 283(44):29929-29937.
2. Beran R.K., Serebrov V., Pyle A.M. The serine protease domain of hepatitis C viral NS3 activates RNA helicase activity by promoting the binding of RNA substrate. Journal of Biological Chemistry 2007, 282(48):34913-34920.
3. Bhardwaj K., Guarino L., Kao C.C. The severe acute respiratory syndrome coronavirus Nsp15 protein is an endoribonuclease that prefers manganese as a cofactor. Journal of Virology 2004, 78(22):12218-12224.
4. Bhardwaj K., Palaninathan S., Alcantara J.M., Yi L.L., Guarino L., Sacchettini J.C., Kao C.C. Structural and functional analyses of the severe acute respiratory syndrome coronavirus endoribonuclease Nsp15. Journal of Biological Chemistry 2008, 283(6):3655-3664.
5. Brass V., Berke J.M., Montserret R., Blum H.E., Penin F., Moradpour D. Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complex. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(38):14545-14550.
6. Casula S., Zolotarev A.S., Stuart-Tilley A.K., Wilhelm S., Shmukler B.E., Brugnara C., Alper S.L. Chemical crosslinking studies with the mouse Kcc1 K-Cl cotransporter. Blood Cells, Molecules and Diseases 2009, 42(3):233-240.
7. Chisari F.V. Unscrambling hepatitis C virus-host interactions. Nature 2005, 436(7053):930-932.
8. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989, 244(4902):359-362.
9. Choo Q.L., Richman K.H., Han J.H., Berger K., Lee C., Dong C., Gallegos C., Coit D., Medina-Selby R., Barr P.J., et al. Genetic organization and diversity of the hepatitis C virus. Proceedings of the National Academy of Sciences of the United States of America 1991, 88(6):2451-2455.
10. Dahl G., Sandstrom A., Akerblom E., Danielson U.H. Effects on protease inhibition by modifying of helicase residues in hepatitis C virus nonstructural protein 3. FEBS Journal 2007, 274(22):5979-5986.
11. Egger D., Wolk B., Gosert R., Bianchi L., Blum H.E., Moradpour D., Bienz K. Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. Journal of Virology 2002, 76(12):5974-5984.
12. Elazar M., Liu P., Rice C.M., Glenn J.S. An N-terminal amphipathic helix in hepatitis C virus (HCV) NS4B mediates membrane association, correct localization of replication complex proteins, and HCV RNA replication. Journal of Virology 2004, 78(20):11393-11400.
13. Feld J.J., Hoofnagle J.H. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature 2005, 436(7053):967-972.
14. Frick D.N. The hepatitis C virus NS3 protein: a model RNA helicase and potential drug target. Current Issues in Molecular Biology 2007, 9:1-20.
15. Frick D.N., Rypma R.S., Lam A.M., Gu B. The nonstructural protein 3 protease/helicase requires an intact protease domain to unwind duplex RNA efficiently. Journal of Biological Chemistry 2004, 279(2):1269-1280.
16. Fukuda K., Umehara T., Sekiya S., Kunio K., Hasegawa T., Nishikawa S. An RNA ligand inhibits hepatitis C virus NS3 protease and helicase activities. Biochemical and Biophysical Research Communications 2004, 325(3):670-675.
17. Fukuda K., Vishnuvardhan D., Sekiya S., Hwang J., Kakiuchi N., Taira K., Shimotohno K., Kumar P.K., Nishikawa S. Isolation and characterization of RNA aptamers specific for the hepatitis C virus nonstructural protein 3 protease. European Journal of Biochemistry 2000, 267(12):3685-3694.
18. Gale M., Foy E.M. Evasion of intracellular host defence by hepatitis C virus. Nature 2005, 436(7053):939-945.
19. Gao L., Aizaki H., He J.W., Lai M.M. Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft. Journal of Virology 2004, 78(7):3480-3488.
20. Gu B., Pruss C.M., Gates A.T., Khandekar S.S. The RNA-unwinding activity of hepatitis C virus non-structural protein 3 (NS3) is positively modulated by its protease domain. Protein and Peptide Letters 2005, 12(4):315-321.
21. Hema M., Murali A., Ni P., Vaughan R.C., Fujisaki K., Tsvetkova I., Dragnea B., Kao C.C. Effects of amino-acid substitutions in the Brome mosaic virus capsid protein on RNA encapsidation. Molecular Plant-Microbe Interactions: MPMI 2010, 23(11):1433-1447.
22. Hwang J., Fauzi H., Fukuda K., Sekiya S., Kakiuchi N., Shimotohno K., Taira K., Kusakabe I., Nishikawa S. The RNA aptamer-binding site of hepatitis C virus NS3 protease. Biochemical and Biophysical Research Communications 2000, 279(2):557-562.
23. Hwang J., Fauzi H., Fukuda K., Sekiya S., Kakiuchi N., Taira K., Kusakabe I., Nishikawa S. Analysis of aptamer binding site for HCV-NS3 protease by alanine scanning mutagenesis. Nucleic Acids Symposium Series 2000, 44:253-254.
24. Isken O., Grassmann C.W., Sarisky R.T., Kann M., Zhang S., Grosse F., Kao P.N., Behrens S.E. Members of the NF90/NFAR protein group are involved in the life cycle of a positive-strand RNA virus. EMBO Journal 2003, 22(21):5655-5665.
25. Jacobo-Molina A., Ding J., Nanni R.G., Clark A.D., Lu X., Tantillo C., Williams R.L., Kamer G., Ferris A.L., Clark P., et al. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. Proceedings of the National Academy of Sciences of the United States of America 1993, 90(13):6320-6324.
26. Janecki D.J., Beardsley R.L., Reilly J.P. Probing protein tertiary structure with amidination. Analytical Chemistry 2005, 77(22):7274-7281.
27. Jurgens C.K., Barton D.J., Sharma N., Morasco B.J., Ogram S.A., Flanegan J.B. 2Apro is a multifunctional protein that regulates the stability, translation and replication of poliovirus RNA. Virology 2006, 345(2):346-357.
28. Kim J.L., Morgenstern K.A., Lin C., Fox T., Dwyer M.D., Landro J.A., Chambers S.P., Markland W., Lepre C.A., O'Malley E.T., Harbeson S.L., Rice C.M., Murcko M.A., Caron P.R., Thomson J.A. Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell 1996, 87(2):343-355.
29. Kolykhalov A.A., Mihalik K., Feinstone S.M., Rice C.M. Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo. Journal of Virology 2000, 74(4):2046-2051.
30. Kwong A.D., Kauffman R.S., Hurter P., Mueller P. Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus. Nature Biotechnology 2011, 29(11):993-1003.
31. Kwong A.D., McNair L., Jacobson I., George S. Recent progress in the development of selected hepatitis C virus NS3-4A protease and NS5B polymerase inhibitors. Current Opinion in Pharmacology 2008, 8(5):522-531.
32. Lam A.M., Frick D.N. Hepatitis C virus subgenomic replicon requires an active NS3 RNA helicase. Journal of Virology 2006, 80(1):404-411.
33. Lauber M.A., Running W.E., Reilly J.P. B. subtilis ribosomal proteins: structural homology and post-translational modifications. Journal of Proteome Research 2009, 8(9):4193-4206.
34. Li K., Foy E., Ferreon J.C., Nakamura M., Ferreon A.C., Ikeda M., Ray S.C., Gale M., Lemon S.M. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:2992-2997.
35. Li K., Foy E., Ferreon J.C., Nakamura M., Ferreon A.C., Ikeda M., Ray S.C., Gale M., Lemon S.M. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(8):2992-2997.
36. Li X.D., Sun L., Seth R.B., Pineda G., Chen Z.J. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(49):17717-17722.
37. Lin R., Lacoste J., Nakhaei P., Sun Q., Yang L., Paz S., Wilkinson P., Julkunen I., Vitour D., Meurs E., Hiscott J. Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage. Journal of Virology 2006, 80(12):6072-6083.
38. Liu X., Reilly J.P. Correlating the chemical modification of Escherichia coli ribosomal proteins with crystal structure data. Journal of Proteome Research 2009, 8(10):4466-4478.
39. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
40. Lohmann V., Korner F., Koch J., Herian U., Theilmann L., Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999, 285:110-113.
41. Love R.A., Parge H.E., Wickersham J.A., Hostomsky Z., Habuka N., Moomaw E.W., Adachi T., Hostomska Z. The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site. Cell 1996, 87(2):331-342.
42. Mackintosh S.G., Lu J.Z., Jordan J.B., Harrison M.K., Sikora B., Sharma S.D., Cameron C.E., Raney K.D., Sakon J. Structural and biological identification of residues on the surface of NS3 helicase required for optimal replication of the hepatitis C virus. Journal of Biological Chemistry 2006, 281(6):3528-3535.
43. Mann B., Madera M., Sheng Q., Tang H., Mechref Y., Novotny M.V. ProteinQuant Suite: a bundle of automated software tools for label-free quantitative proteomics. Rapid Communications in Mass Spectrometry 2008, 22(23):3823-3834.
44. Mederacke I., Wedemeyer H., Manns M.P. Boceprevir, an NS3 serine protease inhibitor of hepatitis C virus, for the treatment of HCV infection. Current Opinion in Investigational Drugs 2009, 10(2):181-189.
45. Meylan E., Curran J., Hofmann K., Moradpour D., Binder M., Bartenschlager R., Tschopp J. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005, 437(7062):1167-1172.
46. Moradpour D., Penin F., Rice C.M. Replication of hepatitis C virus. Nature Reviews Microbiology 2007, 5(6):453-463.
47. Niranjanakumari S., Lasda E., Brazas R., Garcia-Blanco M.A. Reversible cross-linking combined with immunoprecipitation to study RNA-protein interactions in vivo. Methods 2002, 26(2):182-190.
48. Pang P.S., Jankowsky E., Planet P.J., Pyle A.M. The hepatitis C viral NS3 protein is a processive DNA helicase with cofactor enhanced RNA unwinding. EMBO Journal 2002, 21(5):1168-1176.
49. Running W.E., Reilly J.P. Ribosomal proteins of Deinococcus radiodurans: their solvent accessibility and reactivity. Journal of Proteome Research 2009, 8(3):1228-1246.
50. Shen M., Wang Q., Yang Y., Pathak H.B., Arnold J.J., Castro C., Lemon S.M., Cameron C.E. Human rhinovirus type 14 gain-of-function mutants for oriI utilization define residues of 3C(D) and 3Dpol that contribute to assembly and stability of the picornavirus VPg uridylylation complex. Journal of Virology 2007, 81(22):12485-12495.
51. Shepard C.W., Finelli L., Alter M.J. Global epidemiology of hepatitis C virus infection. Lancet Infectious Diseases 2005, 5(9):558-567.
52. Taliani M., Bianchi E., Narjes F., Fossatelli M., Urbani A., Steinkuhler C., De Francesco R., Pessi A. A continuous assay of hepatitis C virus protease based on resonance energy transfer depsipeptide substrates. Analytical Biochemistry 1996, 240(1):60-67.
53. Tan S.L., Pause A., Shi Y., Sonenberg N. Hepatitis C therapeutics: current status and emerging strategies. Nature Reviews Drug Discovery 2002, 1(11):867-881.
54. Taremi S.S., Beyer B., Maher M., Yao N., Prosise W., Weber P.C., Malcolm B.A. Construction, expression, and characterization of a novel fully activated recombinant single-chain hepatitis C virus protease. Protein Science 1998, 7(10):2143-2149.
55. Umehara T., Fukuda K., Nishikawa F., Kohara M., Hasegawa T., Nishikawa S. Rational design of dual-functional aptamers that inhibit the protease and helicase activities of HCV NS3. Journal of Biochemistry 2005, 137(3):339-347.
56. Urvil P.T., Kakiuchi N., Zhou D.M., Shimotohno K., Kumar P.K., Nishikawa S. Selection of RNA aptamers that bind specifically to the NS3 protease of hepatitis C virus. European Journal of Biochemistry 1997, 248(1):130-138.
57. Vaughan R., Running W.E., Qi R., Kao C. Mapping protein-RNA interactions. Virus Adaptation and Treatment 2012, 4(1):29-41.
58. Wang L.C., Okitsu C.Y., Kochounian H., Rodriguez A., Hsieh C.L., Zandi E. A simple and inexpensive on-column frit fabrication method for fused-silica capillaries for increased capacity and versatility in LC-MS/MS applications. Proteomics 2008, 8(9):1758-1761.
59. Yan Y., Li Y., Munshi S., Sardana V., Cole J.L., Sardana M., Steinkuehler C., Tomei L., De Francesco R., Kuo L.C., Chen Z. Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: a 2.2 A resolution structure in a hexagonal crystal form. Protein Science 1998, 7(4):837-847.
60. Yao N., Reichert P., Taremi S.S., Prosise W.W., Weber P.C. Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase. Structure 1999, 7(11):1353-1363.
61. Yi Z., Pan T., Wu X., Song W., Wang S., Xu Y., Rice C.M., Macdonald M.R., Yuan Z. Hepatitis C virus co-opts Ras-GTPase-activating protein-binding protein 1 for its genome replication. Journal of Virology 2011, 85:6996-7004.
62. Yi G., Letteney E., Kim C.H., Kao C.C. Brome mosaic virus capsid protein regulates accumulation of viral replication proteins by binding to the replicase assembly RNA element. RNA-A Publication of the RNA Society 2009, 15(4):615-626.
63. Yi G., Vaughan R.C., Yarbrough I., Dharmaiah S., Kao C.C. RNA binding by the Brome mosaic virus capsid protein and the regulation of viral RNA accumulation. Journal of Molecular Biology 2009, 391(2):314-326.
64. Yi M., Ma Y., Yates J., Lemon S.M. Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. Journal of Virology 2007, 81(2):629-638.
65. Yin J., Paul A.V., Wimmer E., Rieder E. Functional dissection of a poliovirus cis-acting replication element [PV-cre(2C)]: analysis of single- and dual-cre viral genomes and proteins that bind specifically to PV-cre RNA. Journal of Virology 2003, 77(9):5152-5166.
66. Zhang C., Cai Z., Kim Y.C., Kumar R., Yuan F., Shi P.Y., Kao C., Luo G. Stimulation of hepatitis C virus (HCV) nonstructural protein 3 (NS3) helicase activity by the NS3 protease domain and by HCV RNA-dependent RNA polymerase. Journal of Virology 2005, 79(14):8687-8697.
67. Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Research 2003, 31(13):3406-3415.